|
TFG Experience
Nathan has led a wide range of strategic, financial and scientifically oriented engagements. Efforts include work in various therapeutic groups including: oncology, diabetes rheumatology, critical care, infectious disease, dermatology, interventional cardiology, pulmonology, gastroenterology, degenerative neurology, pain management, hematology, and orthopedics. Across those areas of medicine his technology platform experience includes stem cells & tissue engineering, immunotherapeutics & tolerance (e.g., antibodies, vaccines) proteins, peptides & constructs thereof, small molecules, drug delivery and genomics. Nathan's expertise includes forecasting & franchise strategy development, incubator & new business creation, product launch & market planning, business development & investment advisory, new product profile & clinical trial development. Clients have included the research & development, business development, & marketing groups of top 5 global pharmaceutical and biotechnology firms. Nathan has also advised a broad array of smaller medical device, diagnostic, biopharmaceutical, and pharmaceutical firms.
Pre-TFG Experience
Prior to joining TFG Nathan was a consultant with Ernst & Young LLP where his engagement experience included Payor (Mergers & Acquisition, Operational Assessment, IT Systems), and Provider (Mergers & Acquisition, Operational Assessment). Nathan worked at Searle Pharmaceuticals in their Managed Care Strategy group and prior to that was an analyst at CIGNA Healthcare.
Education
Nathan holds an MBA with dual concentrations in Finance & Marketing from The University of Chicago.
| 